Jacobs Levy Equity Management
DNA icon

Jacobs Levy Equity Management’s Ginkgo Bioworks DNA Stock Holding History

Jacobs Levy Equity Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.98M Buy
322,717
+78,298
+32% +$651K 0.01% 591
2025
Q4 		$2.03M Buy
244,419
+173,552
+245% +$1.87M 0.01% 578
2025
Q3 		$1.03M Buy
+70,867
New +$848K ﹤0.01% 709
2024
Q4 		– Sell
-279,954
Closed -$2.28M – 961
2024
Q3 		$2.28M Buy
+279,954
New +$2.81M 0.01% 581
2024
Q1 		– Sell
-6,408
Closed -$433K – 962
2023
Q4 		$433K Hold
6,408
– – ﹤0.01% 847
2023
Q3 		$464K Sell
6,408
-86,593
-93% -$6.92M ﹤0.01% 814
2023
Q2 		$6.92M Sell
93,001
-76,074
-45% -$4.5M 0.04% 330
2023
Q1 		$8.99M Buy
+169,075
New +$10.7M 0.06% 300

Other funds holding DNA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return